Precision Medicine in Neuropathic Pain

Area of Science:

• Neurology
• Pain Medicine
• Clinical Trials

Background:

• Neuropathic pain, caused by somatosensory nervous system damage, significantly impacts patient quality of life.
• Current treatments offer limited efficacy, and drug development trials frequently fail, highlighting an unmet clinical need.
• The heterogeneity of pain mechanisms in neuropathic pain contributes to treatment challenges.

Purpose of the Study:

• To address the unmet need in neuropathic pain by proposing a mechanism-based treatment approach.
• To explore the potential of reclassifying neuropathic pain based on underlying pathophysiological mechanisms rather than disease etiology.
• To identify and present promising predictive biomarkers for stratifying patients in clinical trials.

Main Methods:

• Focus on sensory symptoms and signs as surrogate markers for pain mechanisms.
• Utilize patient-reported outcome measures (PROMs) for assessing sensory experiences.
• Incorporate sensory testing as a key component of patient evaluation.

Main Results:

• Promising predictive biomarkers related to sensory symptoms and signs have been identified.
• Patient-reported outcomes and sensory testing show potential as tools for stratifying patients.
• These methods could facilitate the identification of treatment responders in clinical trials.

Conclusions:

• Stratifying neuropathic pain patients based on underlying mechanisms is crucial for effective treatment.
• Sensory symptoms, signs, PROMs, and sensory testing serve as valuable surrogate markers.
• Future clinical trials can leverage these tools for mechanism-based treatment strategies.